The Reappraisal of Neuropeptide Y as Biomarker and Therapeutic Target in Arrhythmic Disorders

By sjmartinez • March 17, 2025

Zaglia T, Ajijola OA. The Reappraisal of Neuropeptide Y as Biomarker and Therapeutic Target in Arrhythmic Disorders. JACC Clin Electrophysiol. 2025 Feb 24:S2405-500X(25)00068-4. doi: 10.1016/j.jacep.2025.01.012. Epub ahead of print. PMID: 40088221.

Tags: Cardiology/Epi, neuropeptide Y, Publications, sympathetic nervous system, Ventricular arrhythmias

Mitochondrial reactive oxygen species regulate acetyl-CoA flux between cytokine production and fatty acid synthesis in effector T cells

Wu B, Woo JS, Hasiakos S, Pan C, Cokus S, Benincá C, Stiles L, Sun Z, Pellegrini M, Shirihai OS, Lusis AJ, Srikanth S, Gwack[...]

The Ahmanson/UCLA adult congenital heart disease center, at UCLA, los angeles, USA: The history of a leading ACHD institution and its vision for the future

Aboulhosn J. The Ahmanson/UCLA adult congenital heart disease center, at UCLA, los angeles, USA: The history of a leading ACHD institution and its vision for[...]

Proposed enhanced recommendations for interpretation of electrocardiographic screening of athletes

Froelicher V, Husaini M, Tso JV, Montalvo S, Christle J, Perez MV, Hadley D, Wheeler M, Stein R, Vetter V, Hsu JJ, Asif IM, Hedman[...]